HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
CHPS Grants & Awards
CHPS Junior Investigator Preliminary/Feasibility Grant Program (JIPGP)
The Center for Human Phenomic Science (CHPS) is not currently accepting research proposals to be considered for the Junior Investigator Preliminary/Feasibility Grant Program (JIPGP). Applications will reopen in 2025.
The primary goal of the JIPGP is to encourage early-career investigators to develop research projects that will ultimately lead to extramural funding and to a career in clinical and/or translational research. The JIPGP awards are in partnership with the NIH Clinical and Translational Science Award (CTSA), the Institute for Translational Medicine and Therapeutics (ITMAT), and Children's Hospital of Philadelphia (CHOP) Research Institute.
The JIPGP awards are designed to allow junior faculty members and MD, PhD, and DMD Postdoctoral trainees to perform investigator-initiated, human-based, studies utilizing CHPS services. Projects should address CTSA themes of multidisciplinary research, translational research, and research across the age spectrum. The grants will be available at each institution effective July 1, 2024.
AWARD DATES:
- Application Receipt Deadline: March 8, 2024, at Noon
- Notification of Award (tentative): April 19, 2024
- Funding Period: July 1, 2024 – June 30, 2025/6
Grant Submissions – Pre-Award
To add CHPS to a research submission, we recommend that you reach out to the Directors of the Cores that you plan to use to discuss your research. Please contact the CHPS Administrative Staff to discuss the cost of CHPS services and other logistical issues.
To facilitate grant and IRB submissions, CHPS has developed standardized information that study teams can use.
If you would like a letter of support, email John Krall, Administrative Director, at least two weeks prior to the date you need the letter. Include the title of your project, the aims/objectives, hypothesis, funding source/grant type and a detailed list of CHPS services you will requesting. Please supply the budget developed by CTFM.
Pricing requests for CHPS services are submitted through SIFTER when CHPS pricing is required for an eSPA submission. SIFTER, which resides within eIRB, serves as a centralized repository for study start-up information required to support various processes associated with OnCore. For more detailed information, visit Facilitate Clinical Research Study Budget Plan.
If you plan to use CHPS at Penn, please reach out directly at the Penn Center for Human Phenomic Science.
Mentored-Training Awards
For junior faculty on institutional K slots and post-doctoral fellows on institutional T32 slots or equivalent mentored-training awards, CHPS may be able to waive charges for nursing, biostatistics, and Informatics Core services. For additional Core requests, provide mentor's Other Support, including overlap with the trainee's project.
Career Development Award
If you are applying for a career development award, we recommend that you reach out to the directors of the Cores that you plan to use to discuss your research.
Please contact the CHPS Administrative Staff to discuss the cost of CHPS services and other logistical issues. To request a fee waiver, email John Krall, administrative director, at and include the title of your project, the aims/objectives, hypothesis, funding source/grant type and a detailed list of CHPS services you will requesting.
You are also required to obtain a Price Request through Clinical Trials Financial Management that lists all the CHPS services utilized by this project and their cost. Please provide a copy of the completed budget. Also, let us know if you would like a letter of support for your project. Once we receive the request and budget, CHPS leadership will review and determine if we are able to support the research.
Citing CHPS in Publications
CHPS was awarded with funds from National Center for Advancing Translational Sciences (NCATS) July 1, 2016 through June 30, 2026. Please reference the CTSA grant number on all publications/products as follows:
"The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR001878.”